Management Team

Keith Rubin, M.D.
Founder and Chief Executive Officer
Ken Solovay
Chief Operating Officer

Stephanie Noviello, M.D., M.P.H.
Vice President and Global Head of Clinical Development
André Morais Campos
Vice President of Global Clinical Operations
Stanley Kim, Ph.D., Esq.
Senior Vice President, Intellectual Property and Contracts
Marcel Thalen, Ph.D.
Executive Director, Drug Product Development

Peter Goldstein
Senior Director, Vaccine Platform Development
Anil Vaidya
Senior Director, Scientific and Regulatory Writing / Communications
Theressa Creighton
Senior Clinical Project Manager
Steve Glazer, M.D.
Director, New Research Programs

Walter Greenblatt
Corporate Development
Jim Ramadei
Matthew Bross
Administrative Manager

Copyright 2013-2021 ILiAD Biotechnologies